Compare LIVN & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIVN | TBBK |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.6B |
| IPO Year | 1993 | 2004 |
| Metric | LIVN | TBBK |
|---|---|---|
| Price | $64.07 | $69.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $62.43 | ★ $68.00 |
| AVG Volume (30 Days) | ★ 629.3K | 462.0K |
| Earning Date | 11-05-2025 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.10 |
| EPS | N/A | ★ 4.78 |
| Revenue | ★ $1,348,962,000.00 | $523,163,000.00 |
| Revenue This Year | $12.25 | N/A |
| Revenue Next Year | $6.75 | $32.53 |
| P/E Ratio | ★ N/A | $14.38 |
| Revenue Growth | 8.63 | ★ 10.84 |
| 52 Week Low | $32.48 | $40.51 |
| 52 Week High | $64.45 | $81.65 |
| Indicator | LIVN | TBBK |
|---|---|---|
| Relative Strength Index (RSI) | 67.35 | 61.79 |
| Support Level | $61.81 | $65.23 |
| Resistance Level | $64.45 | $67.43 |
| Average True Range (ATR) | 1.91 | 2.06 |
| MACD | 0.17 | 0.99 |
| Stochastic Oscillator | 95.81 | 96.30 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.